Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1880056623;56624;56625 chr2:178599395;178599394;178599393chr2:179464122;179464121;179464120
N2AB1715951700;51701;51702 chr2:178599395;178599394;178599393chr2:179464122;179464121;179464120
N2A1623248919;48920;48921 chr2:178599395;178599394;178599393chr2:179464122;179464121;179464120
N2B973529428;29429;29430 chr2:178599395;178599394;178599393chr2:179464122;179464121;179464120
Novex-1986029803;29804;29805 chr2:178599395;178599394;178599393chr2:179464122;179464121;179464120
Novex-2992730004;30005;30006 chr2:178599395;178599394;178599393chr2:179464122;179464121;179464120
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAT
  • RefSeq wild type template codon: CTA
  • Domain: Fn3-24
  • Domain position: 17
  • Structural Position: 18
  • Q(SASA): 0.697
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/Y rs764411398 -0.36 0.99 N 0.611 0.451 0.586694575381 gnomAD-2.1.1 1.85E-05 None None None None N None 0 0 None 0 0 None 0 None 5.06E-05 2.98E-05 0
D/Y rs764411398 -0.36 0.99 N 0.611 0.451 0.586694575381 gnomAD-4.0.0 1.69422E-06 None None None None N None 0 0 None 0 0 None 1.92864E-05 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.2262 likely_benign 0.2523 benign -0.472 Destabilizing 0.698 D 0.457 neutral N 0.506707157 None None N
D/C 0.6592 likely_pathogenic 0.6742 pathogenic 0.089 Stabilizing 0.998 D 0.655 neutral None None None None N
D/E 0.1141 likely_benign 0.1156 benign -0.574 Destabilizing 0.006 N 0.169 neutral N 0.428342374 None None N
D/F 0.6307 likely_pathogenic 0.645 pathogenic -0.667 Destabilizing 0.993 D 0.612 neutral None None None None N
D/G 0.2003 likely_benign 0.22 benign -0.695 Destabilizing 0.822 D 0.498 neutral N 0.509592747 None None N
D/H 0.3275 likely_benign 0.3524 ambiguous -0.881 Destabilizing 0.992 D 0.485 neutral N 0.494855368 None None N
D/I 0.4592 ambiguous 0.4796 ambiguous 0.079 Stabilizing 0.978 D 0.617 neutral None None None None N
D/K 0.4223 ambiguous 0.4246 ambiguous 0.135 Stabilizing 0.754 D 0.475 neutral None None None None N
D/L 0.4099 ambiguous 0.4193 ambiguous 0.079 Stabilizing 0.956 D 0.611 neutral None None None None N
D/M 0.5888 likely_pathogenic 0.609 pathogenic 0.509 Stabilizing 0.998 D 0.597 neutral None None None None N
D/N 0.1091 likely_benign 0.1074 benign -0.105 Destabilizing 0.822 D 0.545 neutral N 0.466935261 None None N
D/P 0.8812 likely_pathogenic 0.9208 pathogenic -0.082 Destabilizing 0.978 D 0.507 neutral None None None None N
D/Q 0.2894 likely_benign 0.3018 benign -0.099 Destabilizing 0.915 D 0.472 neutral None None None None N
D/R 0.4761 ambiguous 0.4934 ambiguous 0.091 Stabilizing 0.956 D 0.575 neutral None None None None N
D/S 0.1311 likely_benign 0.1339 benign -0.257 Destabilizing 0.754 D 0.485 neutral None None None None N
D/T 0.2154 likely_benign 0.224 benign -0.081 Destabilizing 0.956 D 0.437 neutral None None None None N
D/V 0.2869 likely_benign 0.3034 benign -0.082 Destabilizing 0.942 D 0.595 neutral N 0.480802987 None None N
D/W 0.8686 likely_pathogenic 0.8838 pathogenic -0.596 Destabilizing 0.998 D 0.655 neutral None None None None N
D/Y 0.3055 likely_benign 0.2907 benign -0.439 Destabilizing 0.99 D 0.611 neutral N 0.503262108 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.